-- Amgen's Bone Drug Prolia Gets Final Approval From U.K. Health-Cost Agency
-- B y   P h i l   S e r a f i n o
-- 2010-10-26T23:01:00Z
-- http://www.bloomberg.com/news/2010-10-26/amgen-s-bone-strengthening-drug-gets-final-approval-from-u-k-cost-agency.html
Amgen Inc. ’s bone-strengthening drug
Prolia should be provided to women at risk of fractures who
can’t take existing drugs, said a U.K. agency that advises the
state-run  National Health Service  on cost-effective treatments.  The  National Institute for Health and Clinical Excellence 
issued the final guidance today on Prolia, which increases bone
mass and strength, the agency said in a statement. The institute
published a preliminary decision in June.  To contact the reporter on this story:
 Phil Serafino  in Paris at 
 pserafino@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at   pserafino@bloomberg.net  